Oruka Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Oruka Therapeutics, Inc. (ORKA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.69 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-10
- Oruka Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 203.28K shares, a 49.57% decline year-over-year.
- Oruka Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 1.48M shares, a 12.65% decline year-over-year.
- Oruka Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 161.60K shares.
- Oruka Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 178.00K shares.
- Oruka Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 2.44M shares.
- Oruka Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 60.00K shares, a 86.17% decline from fiscal 2021.
- Oruka Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 433.70K shares, a 13.32% decline from fiscal 2020.
- Oruka Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 500.35K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 8 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 11 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 203.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | 1.69M shares 10-Q · filed 2026-08-10 | 1.85M shares derived: sum of 3 quarters · filed 2026-08-10 | 2.03M shares derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2026-03-31 | 1.48M shares 10-Q · filed 2026-05-13 | 1.64M shares derived: sum of 2 quarters · filed 2026-05-13 | 1.82M shares derived: sum of 3 quarters · filed 2026-05-13 | 2.23M shares derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2025-12-31 | 161.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 339.60K shares derived: sum of 2 quarters · filed 2026-03-12 | 742.70K shares derived: sum of 3 quarters · filed 2026-03-12 | 2.44M shares 10-K · filed 2026-03-12 | |||
| 2025-09-30 | 178.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 581.10K shares derived: sum of 2 quarters · filed 2025-11-12 | 2.28M shares 10-Q · filed 2025-11-12 | ||||
| 2025-06-30 | 403.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 2.10M shares 10-Q · filed 2025-08-11 | |||||
| 2025-03-31 | 1.70M shares 10-Q · filed 2025-05-14 | ||||||
| 2024-12-31 | 1.57M shares 10-K · filed 2025-03-06 | ||||||
| 2024-09-30 | 1.29M shares 10-Q · filed 2024-11-13 | ||||||
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 42.00K shares 10-Q · filed 2024-08-01 | |||||
| 2024-03-31 | 42.00K shares 10-Q · filed 2024-04-25 | ||||||
| 2022-12-31 | 48.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | 48.00K shares derived: sum of 2 quarters · filed 2024-02-01 | 60.00K shares 10-K · filed 2024-02-01 | ||||
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | 12.00K shares 10-Q · filed 2022-10-28 | |||||
| 2022-06-30 | 12.00K shares 10-Q · filed 2022-08-02 | ||||||
| 2021-12-31 | 263.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | 286.50K shares derived: sum of 2 quarters · filed 2023-02-24 | 366.50K shares derived: sum of 3 quarters · filed 2023-02-24 | 433.70K shares 10-K · filed 2023-02-24 | |||
| 2021-09-30 | 23.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | 103.00K shares derived: sum of 2 quarters · filed 2021-11-02 | 170.20K shares 10-Q · filed 2021-11-02 | 664.30K shares derived: sum of 4 quarters · filed 2022-03-14 | |||
| 2021-06-30 | 80.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | 147.20K shares 10-Q · filed 2021-08-04 | 641.30K shares derived: sum of 3 quarters · filed 2022-03-14 | ||||
| 2021-03-31 | 67.20K shares 10-Q · filed 2021-05-11 | 561.30K shares derived: sum of 2 quarters · filed 2022-03-14 | |||||
| 2020-12-31 | 494.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | 500.35K shares 10-K · filed 2022-03-14 | |||||
| 2020-09-30 | 6.25K shares 10-Q · filed 2020-11-02 | ||||||
| 2018-12-31 | -37.78K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -37.78K shares derived: sum of 2 quarters · filed 2020-02-18 | -37.78K shares derived: sum of 3 quarters · filed 2020-02-18 | 2.22K shares 10-K · filed 2020-02-18 | 40.00K shares 10-K · filed 2019-02-27 | ||
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2018-11-14 | 40.00K shares 10-Q · filed 2018-11-14 | 40.00K shares derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 40.00K shares 10-Q · filed 2018-08-09 | 40.00K shares derived: sum of 3 quarters · filed 2019-02-27 | 40.00K shares derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2018-03-31 | 40.00K shares 10-Q · filed 2018-05-08 | 40.00K shares derived: sum of 2 quarters · filed 2019-02-27 | 40.00K shares derived: sum of 3 quarters · filed 2019-02-27 | 40.00K shares derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | 0.00 shares derived: sum of 2 quarters · filed 2019-02-27 | 0.00 shares derived: sum of 3 quarters · filed 2019-02-27 | 469.60K shares 10-K · filed 2019-02-27 | |||
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 0.00 shares derived: sum of 2 quarters · filed 2017-11-09 | 469.60K shares 10-Q · filed 2017-11-09 | 515.00K shares derived: sum of 4 quarters · filed 2018-03-22 | |||
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 469.60K shares 10-Q · filed 2017-08-03 | 515.00K shares derived: sum of 3 quarters · filed 2018-03-22 | 515.00K shares derived: sum of 4 quarters · filed 2018-03-22 | |||
| 2017-03-31 | 469.60K shares 10-Q · filed 2017-05-15 | 515.00K shares derived: sum of 2 quarters · filed 2018-03-22 | 515.00K shares derived: sum of 3 quarters · filed 2018-03-22 | 925.30K shares derived: sum of 4 quarters · filed 2018-03-22 | |||
| 2016-12-31 | 45.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | 45.40K shares derived: sum of 2 quarters · filed 2018-03-22 | 455.70K shares derived: sum of 3 quarters · filed 2018-03-22 | 487.70K shares 10-K · filed 2018-03-22 | |||
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 410.30K shares derived: sum of 2 quarters · filed 2016-11-14 | 442.30K shares 10-Q · filed 2016-11-14 | 443.60K shares derived: sum of 4 quarters · filed 2017-03-21 | |||
| 2016-06-30 | 410.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | 442.30K shares 10-Q · filed 2016-08-09 | 443.60K shares derived: sum of 3 quarters · filed 2017-03-21 | 326.41K shares derived: sum of 4 quarters · filed 2017-03-21 | |||
| 2016-03-31 | 32.00K shares 10-Q · filed 2016-05-11 | 33.30K shares derived: sum of 2 quarters · filed 2017-03-21 | -83.89K shares derived: sum of 3 quarters · filed 2017-03-21 | -68.29K shares derived: sum of 4 quarters · filed 2017-03-21 | |||
| 2015-12-31 | 1.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | -115.89K shares derived: sum of 2 quarters · filed 2017-03-21 | -100.29K shares derived: sum of 3 quarters · filed 2017-03-21 | 21.49K shares 10-K · filed 2017-03-21 | |||
| 2015-09-30 | -117.19K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -101.59K shares derived: sum of 2 quarters · filed 2015-11-12 | 20.19K shares 10-Q · filed 2015-11-12 | -147.24K shares derived: sum of 4 quarters · filed 2016-03-17 | |||
| 2015-06-30 | 15.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | 137.38K shares 10-Q · filed 2015-08-11 | -30.05K shares derived: sum of 3 quarters · filed 2016-03-17 | -30.05K shares derived: sum of 4 quarters · filed 2016-03-17 | |||
| 2015-03-31 | 121.78K shares 10-Q · filed 2015-05-12 | -45.66K shares derived: sum of 2 quarters · filed 2016-03-17 | -45.66K shares derived: sum of 3 quarters · filed 2016-03-17 | -45.66K shares derived: sum of 4 quarters · filed 2016-03-17 | |||
| 2014-12-31 | -167.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-17 | -167.44K shares derived: sum of 2 quarters · filed 2016-03-17 | -167.44K shares derived: sum of 3 quarters · filed 2016-03-17 | 32.64K shares 10-K · filed 2016-03-17 | 228.58K shares 10-K · filed 2015-03-19 | ||
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2014-11-12 | 200.08K shares 10-Q · filed 2014-11-12 | 210.08K shares derived: sum of 4 quarters · filed 2015-03-19 | |||
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | 200.08K shares 10-Q · filed 2014-08-13 | 210.08K shares derived: sum of 3 quarters · filed 2015-03-19 | ||||
| 2014-03-31 | 200.08K shares 10-Q · filed 2014-05-13 | 210.08K shares derived: sum of 2 quarters · filed 2015-03-19 | |||||
| 2013-12-31 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | 741.53K shares 10-K · filed 2015-03-19 | |||||
| 2013-09-30 | 731.53K shares 10-Q · filed 2013-11-13 | ||||||
| 2012-12-31 | -29.17K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | -29.17K shares derived: sum of 2 quarters · filed 2014-03-20 | 5.83K shares 10-K · filed 2014-03-20 | ||||
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | 35.00K shares 10-Q · filed 2012-11-13 | |||||
| 2012-06-30 | 35.00K shares 10-Q · filed 2012-08-13 | ||||||
| 2011-12-31 | 27.45K shares 10-K · filed 2013-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |